Events in the Series
World RNA Conference Calendar
We have seen enormous strides in the developments and breakthroughs in RNA-based vaccines, RNA-based therapeutics and targeting RNA fields since the onset of the global pandemic. Keeping pace with the field's rapid advancements, the World RNA Series from Hanson Wade continues to provide unrivaled industry-focused events to help deliver safe and effective RNA therapies to patients faster.
Get a comprehensive overview of the upcoming events within the World RNA Series portfolio below. If you have any questions, get in touch at email@example.com.
Advance Your mRNA Pipelines to Front-Line Treatments by Successfully Translating Proof-of-Concepts with Safety, Efficacy & Regulatory Approval
Streamlining Purification, Yield & Scalability of Plasmid & Enzymatic DNA to Harmonize with Regulatory Expectations & Meet Increasing Global Demand for Quality Therapeutics & Vaccines
Accelerating the End to End of mRNA Process Development & Manufacturing, From Research to Commercial Scale Maximizing Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
Unlock mRNA Platforms for Next Generation Therapeutics & Vaccines from Concept to Clinical Validation & Commercialization for Patients in Need Across All Disease Indications
Accelerating mRNA Process Development & Manufacturing from Research to Commercial Scale with Increased Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
Developing Sensitive & Robust Bioanalytical, Analytical & Potency Assays to Accurately Measure Quality, Expression & Efficacy for
Accelerated mRNA Drug Development
Accelerating Extrahepatic Delivery, CMC & Clinical Development of Targeted siRNA Therapeutics for Modular, Reproducible & Effective Gene Silencing Therapies Against Oncology, CNS, Rare Diseases & Beyond
Stay Ahead of the Curve with Novel RNA Therapeutics that Offer Exceptional Stability & Durability Whilst Addressing Key Delivery, Pharmacology & Scalability Challenges to Successfully Translate Safe & Effective Next Generation RNA Therapeutics into the Clinic
Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve GMP Manufacturing for Effective Translation into the Clinic & Towards Commercialization